For reference: date of analysis · HJ.
I would like to define my thresholds before I have a result, for obvious reasons.
I want a plan with explicit stopping rules, not just steps.
What does a sensible plan look like, and what are the decision points?
Worth being precise here: ask whether the certificate answers the question you are actually asking, because the answer is often no.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 21 Mar 2025 by Dr_Wren_Halliday — added the placebo-arm figures
Worth being precise here: what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Stated carefully, the field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
If the certificate does not trace to your vial, it is not evidence about your vial.
Reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
A certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.